Translating Advanced Cancer Research into Personalized, Compassionate Care
Saint John’s Cancer Institute is renowned research facility dedicated to advanced therapeutics, translational sciences, and best medical practices. We promote robust fellowship programs and clinical trials, collaborating with industry and academic partners worldwide.
Read MoreInnovation Starts Here
Saint John’s Cancer Institute (SJCI) is a pioneer in drug discovery, therapeutics, clinical trials, and research. SJCI established the Sentinel Lymph Node Biopsy under the late Dr. Donald L. Morton, which has become the standard of lymph node care for melanoma and breast cancer worldwide.
Today, our patients continue to have access to innovative treatments, therapeutics, and trials. We are at the forefront of understanding the biology of cancer as well as expanding treatment for under-served communities.
Learn More
Treating recurrent glioblastoma with electronic Interoperative Radiation Therapy (IORT)
“…an incredible achievement for everyone involved, especially for PNI and our Saint John’s Cancer Institute.”
– Michael Ricks, Providence Saint John’s Chief Executive
Learn more about PNI: Visit Pacific Neuroscience Institute
Press Release: Saint John’s first in the nation to treat glioblastoma patient with revolutionary radiation therapy – Providence
A Legacy of Research Excellence
“He was ahead of his peers in anticipating the genetics era of cancer research, for decades he carefully maintained archival specimen resource for correlative translational studies.”
– Laura Morton Rowe, Chief Human Resources Officer, Saint John’s Health Center
Providence Saint John’s Health Center contributes $2 million to Stand Up To Cancer Dream Team’s Effort to Reduce Disparities in Colorectal Cancer Screenings
Co-leading the Dream Team is Dr. Anton Bilchik
“This team has a tremendous opportunity to create solutions that can be used as national models for integrated colorectal cancer outreach and screening.”
– Anton Bilchik, M.D.
A Novel Clinical Trial for Prostate Cancer
VIDEO & BLOG: White Button Mushroom >
“We have had prior evidence that it may have anti-cancer activity in patients with early-stage prostate cancer.”
– Przemyslaw Twardowski, M.D., Principle Investigator
ACTIVE CLINICAL TRIALS >
RFA Treatment for Benign Thyroid Nodules
Thyroid Radiofrequency Ablation >
“We are now one of the only centers in the Southwest and Westcoast to offer this new procedure for patients.”
– Melanie GoldFarb, M.D.
Center of Excellence: Endocrine – Saint John’s Cancer Institute
Press Release: Thyroid RFA, a first for Providence, gives patients a non-surgical treatment pathway at Saint John’s Health Center – Providence
Featured Publications
